The juxtacapsular nucleus of the anterior division of the BNST (jcBNST) receives robust glutamatergic projections from the basolateral nucleus of the amygdala (BLA), the postpiriform transition area, and the insular cortex as well as dopamine (DA) inputs from the midbrain. In turn the jcBNST sends GABAergic projections to the medial division of the central nucleus of the amygdala (CEAm) as well as other brain regions. We recently described a form of long-term potentiation of the intrinsic excitability (LTP-IE) of neurons of the juxtacapsular nucleus of BNST (jcBNST) in response to high-frequency stimulation (HFS) of the stria terminalis that was impaired during protracted withdrawal from alcohol, cocaine, and heroin and in rats chronically treated with corticotropin-releasing factor (CRF) intracerebroventricularly. Here we show that DAergic neurotransmission is required for the induction of LTP-IE of jcBNST neurons through dopamine (DA) D1 receptors. Thus, activation of the central CRF stress system and altered DAergic neurotransmission during protracted withdrawal from alcohol and drugs of abuse may contribute to the disruption of LTP-IE in the jcBNST. Impairment of this form of intrinsic neuronal plasticity in the jcBNST could result in inadequate neuronal integration and reduced inhibition of the CEA, contributing to the negative affective state that characterizes protracted abstinence in post-dependent individuals. These results provide a novel neurobiological target for vulnerability to alcohol and drug dependence.
Introduction
Neuroadaptive changes in the extended amygdala circuits are believed to be key in the motivation for excessive alcohol and drug intake (Koob et al., 1998) . In particular, many motivational aspects of addiction have been localized to the central nucleus of the amygdala and the lateral subdivision of the bed nucleus of the stria terminalis (BNST) (Koob, 2003) . The BNST is a collection of about a dozen nuclei that are well positioned to integrate somatomotor, autonomic and affective responses. Multiple reinforcing drugs including nicotine, morphine, ethanol, and cocaine were found to increase dialysate DA in the BNST (Carboni et al., 2000) . Additionally, D1-class (D1/D5) DA receptors in the dorsolateral BNST have been implicated in the reinforcing properties of self-administered cocaine (Epping-Jordan et al., 1998) and alcohol (Eiler et al., 2003) . The BNST has also been shown to be critical in mediating stress-induced reinstatement of cocaine self-administration in rodent models (Shaham et al., 2000) . The BNST is also believed to play a central role in the regulation of stress response and in the long-term actions of drugs of abuse (Epping-Jordan et al., 1998; Aston-Jones et al., 1999; Delfs et al., 2000; Georges and Aston-Jones, 2001; Koob, 2003) . Extracellular corticotropin-releasing factor (CRF) levels are increased in the BNST during ethanol withdrawal, and such an increase is reduced by subsequent ethanol intake (Olive et al., 2002) .
The juxtacapsular nucleus of the BNST (jcBNST) is a small nucleus in the dorsal anterolateral BNST that is bounded laterally by the internal capsule and the caudoputamen complex, ventrally by the anterior commissure, and medially by the oval nucleus of the BNST (McDonald et al., 1999; Shammah-Lagnado and Santiago, 1999; Dong et al., 2001; Larriva-Sahd, 2004) . The jcBNST contains gammaaminobutyric acid (GABA)ergic neurons, lacks glutamatergic neurons (Larriva-Sahd, 2006; Francesconi et al., 2009) Abbreviations: 4-AP, 4-aminopyridine; α-DTX, α-dendrotoxin; AMPA, α-hydroxy-5-methyl-4-isoazolepropionic acid; APir, amygdalopiriform transition area; jcBNST, juxtacapsular nucleus of the anterior division of the BNST; BLA, basolateral nucleus of the amygdala; BNST, bed nucleus of the stria terminalis; CEA, central nucleus of the amygdala; CEAm, central nucleus of the amygdala, medial division; CRF, corticotropin releasing factor; DA, dopamine; DAT, dopamine transporter; EPSP, excitatory postsynaptic potential; HFS, high-frequency stimulation; GABA, gamma-aminobutyrate; 
